Ripple kopen? Dit zijn de mogelijkheden

Gilead Sciences Aandeel

66,89USD -0,28USD -0,42%
<
Bedrijf
Kalender
Profiel
>
<
Gerelateerd
Obligaties
>

Gilead Sciences Inc. - Profiel

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. Its primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Aandeelhouder

Eigenaar in %
The Vanguard Group, Inc.7,81
Capital Research & Management Co. (Global Investors)6,13
BlackRock Fund Advisors5,21
SSgA Funds Management, Inc.4,60
Geode Capital Management LLC1,38
Dodge & Cox1,34
Northern Trust Investments, Inc.1,32
Capital Research & Management Co. (World Investors)1,27
Invesco Capital Management LLC1,04
Parnassus Investments1,03
Norges Bank Investment Management1,00
Fidelity Management & Research Co.0,97
T. Rowe Price Associates, Inc.0,94
BlackRock Investment Management (UK) Ltd.0,93
Sanders Capital LLC0,89

Adres

333 Lakeside Drive, 94404 Foster City
Postbus:
Telefoon: 16505743000
Fax: 16505789264
Internet: http://www.gilead.com

Management

Robin L. Washington MBA, CPA
CFO, Chief Accounting Officer & Executive VP
Daniel O'Day, MBA
Chairman & Chief Executive Officer
Gregg H. Alton
Chief Patient Officer
John G. McHutchison, MD
Chief Scientific Officer
George Pratt Shultz, PhD
Director-Emeritus
Andrew D. Dickinson
Executive VP-Corporate Development & Strategy
Laura Hamill
Executive VP-Worldwide Commercial Operations
Katie L. Watson
Executive Vice President-Human Resources
William A. Lee, PhD
Executive Vice President-Research
Gayle Edlund Wilson
Independent Director
Jacqueline K. Barton, PhD
Independent Director
Per Wold-Olsen, MBA
Independent Director
Kevin E. Lofton
Independent Director
Harish M. Manwani
Independent Director
Richard J. Whitley, MD
Independent Director
Kelly A. Kramer
Independent Director
John Francis Cogan, PhD
Lead Independent Director
Brett A. Pletcher
Secretary, Chief Compliance Officer & Executive VP
Diana Brainard, MD
Senior VP-HIV & Emerging Viral Infections
Michael Louie
Vice President-Information Systems
Sung Lee
Vice President-Investor Relations

Invoer toevoegen